[CAS NO. 866460-33-5]  Setipiprant (ACT-129968)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [866460-33-5]

Store
Catalog
SLK-S5753
Brand
Selleck
CAS
866460-33-5

DESCRIPTION [866460-33-5]

Overview

MDLMFCD23136043
Molecular Weight402.42
Molecular FormulaC24H19FN2O3
SMILESC(C(O)=O)N1C2=C(C=3C1=CC=C(F)C3)CN(C(=O)C=4C5=C(C=CC4)C=CC=C5)CC2

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.4850 mL12.4248 mL24.8497 mL
5 mM0.4970 mL2.4850 mL4.9699 mL
10 mM0.2485 mL1.2425 mL2.4850 mL
50 mM0.0497 mL0.2485 mL0.4970 mL

Description

Setipiprant (ACT-129968, KYTH-105) is a selective, orally available antagonist of the that that has been shown to have greater specificity for DP2 (CRTH2) than for DP1.

Synonyms

5H-Pyrido[4,3-b]indole-5-acetic acid, 8-fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-
8-Fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-5H-pyrido[4,3-b]indole-5-acetic acid
Setipiprant
ACT 129968
2-(2-(1-Naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid